View in EDS HTML Full Text PDF Full Text

Efficacy and safety of geptanolimab (GB226) for relapsed or refractory peripheral T cell lymphoma: an open-label phase 2 study (Gxplore-002).

Saved in:
Bibliographic Details
Title: Efficacy and safety of geptanolimab (GB226) for relapsed or refractory peripheral T cell lymphoma: an open-label phase 2 study (Gxplore-002).
Authors: Shi, Yuankai1 (AUTHOR) syuankai@cicams.ac.cn, Wu, Jianqiu2 (AUTHOR), Wang, Zhen3 (AUTHOR), Zhang, Liling4 (AUTHOR), Wang, Zhao5 (AUTHOR), Zhang, Mingzhi6 (AUTHOR), Cen, Hong7 (AUTHOR), Peng, Zhigang8 (AUTHOR), Li, Yufu9 (AUTHOR), Fan, Lei10 (AUTHOR), Guo, Ye11 (AUTHOR), Ma, Liping12 (AUTHOR), Cui, Jie13 (AUTHOR), Gao, Yuhuan14 (AUTHOR), Yang, Haiyan15 (AUTHOR), Zhang, Hongyu16 (AUTHOR), Wang, Lin17 (AUTHOR), Zhang, Weihua18 (AUTHOR), Zhang, Huilai19 (AUTHOR), Xie, Liping20 (AUTHOR)
Source: Journal of Hematology & Oncology. 1/13/2021, Vol. 14 Issue 1, p1-13. 13p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:17568722
DOI:10.1186/s13045-021-01033-1